Skip to main content
SpringerLink
Log in

RETRACTED ARTICLE: Type 1 Diabetes Mellitus is an Independent Risk Factor for Pulmonary Fibrosis

  • Original Paper
  • Published:
Cell Biochemistry and Biophysics Aims and scope Submit manuscript

This article was retracted on 14 February 2023

This article has been updated

Abstract

The objective of this study was to assess the clinical and histopathological relationship between pulmonary fibrosis and type 1 diabetes. We examined clinical pulmonary function parameters and transbronchial lung biopsies to assess associated histopathological changes in 12 type 1 diabetic patients presenting with dyspnea. Lung CT images pulmonary function tests from 12 diabetic patients without dyspnea and from 12 matched normal subjects served as controls. A similar histopathological analysis, including cytokine levels and pro-fibrotic markers, was performed on lung tissues in mice after the induction of experimental diabetes in an attempt to strengthen the link between diabetes and pulmonary fibrosis. Pulmonary function parameters (FVC, FEV1, TLC, and DLco/VA) were significantly reduced in diabetic patients with dyspnea and without dyspnea, compared to controls. Both patient groups also had increased lung CT scores and symptoms compared to normal controls, though the greatest increases were in the diabetic patients with dyspnea. Chronic hyperglycemia induced in mice led to histopathological changes in the lungs that were similar to those found in the human diabetic subjects and included alveoli compression by hyperplastic interstitium infiltrated with inflammatory cells and fibrotic in nature. Two inflammatory related genes, TNF-α and PAI-1, and two fibrosis-related genes, CTGF and fibronectin, demonstrated increased mRNA and protein expression in diabetic mouse lungs. In conclusion, there were significant clinical and histopathological correlations between pulmonary fibrosis and the presence of type 1 diabetes. Diabetes was clinically associated with pulmonary fibrosis and dysfunction in humans, and diabetes induction led to a similar pulmonary fibrosis in an experimental model. These clinical and non-clinical data suggest that diabetes is an independent risk factor for pulmonary fibrosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Change history

References

  1. Okada, M., Suzuki, K., Matsumoto, M., et al. (2009). Effect of angiotensin on the expression of fibrosis-associated cytokines, growth factors, and matrix proteins in human lung fibroblasts. Journal of Clinical Pharmacy and Therapeutics,34, 289–299.

    Article  CAS  Google Scholar 

  2. Ehrlich, S. F., Quesenberry, C. P, Jr, Van Den Eeden, S. K., Shan, J., & Ferrara, A. (2010). Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer. Diabetes Care,33, 55–60.

    Article  PubMed  Google Scholar 

  3. Watter, L. C., King, T. E., Schwarz, M. I., et al. (1986). A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. American Review of Respiratory Disease,133(1), 97–103.

    Article  Google Scholar 

  4. Zhou, G., Li, X., Hein, D. W., Xiang, X., Marshall, J. P., Prabhu, S. D., et al. (2008). Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart. Journal of the American College of Cardiology,52, 655–666.

    Article  CAS  PubMed  Google Scholar 

  5. Wang, J., Song, Y., Elsherif, L., Song, Z., Zhou, G., Prabhu, S. D., et al. (2006). Cardiac metallothionein induction plays the major role in the prevention of diabetic cardiomyopathy by zinc supplementation. Circulation,113, 544–554.

    Article  CAS  PubMed  Google Scholar 

  6. Cai, L., Wang, Y., Zhou, G., Chen, T., Song, Y., Li, X., et al. (2006). Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy. Journal of the American College of Cardiology,48, 1688–1697.

    Article  CAS  PubMed  Google Scholar 

  7. Sandler, M. (1990). Is the lung a ‘target organ’ in diabetes mellitus? Archives of Internal Medicine,150, 1385–1388.

    Article  CAS  PubMed  Google Scholar 

  8. van Gent, R., Brackel, H. J., de Vroede, M., & van der Ent, C. K. (2002). Lung function abnormalities in children with type I diabetes. Respiratory Medicine,96, 976–978.

    Article  PubMed  Google Scholar 

  9. Nicolaie, T., Zavoianu, C., & Nuta, P. (2003). Pulmonary involvement in diabetes mellitus. Romanian Journal of Internal Medicine,41, 365–374.

    CAS  PubMed  Google Scholar 

  10. HsiaC, C., & Raskin, P. (2007). Lung function changes related to diabetes mellitus. Diabetes Technology & Therapeutics,9(Suppl 1), S73–S82.

    Article  Google Scholar 

  11. Vracko, R., Thorning, D., & Huang, T. W. (1979). Basal lamina of alveolar epithelium and capillaries: Quantitative changes with aging and in diabetes mellitus. American Review of Respiratory Disease,120, 973–983.

    CAS  PubMed  Google Scholar 

  12. Weynanda, B., Jonckheere, A., Fransb, A., & Rahier, J. (1999). Diabetes mellitus induces a thickening of the pulmonary basal lamina. Respiration,66, 14–19.

    Article  Google Scholar 

  13. Kodolova, I. M., Lysenko, I. V., & Saltykov, B. B. (1982). Changes in the lung in diabetes mellitus. Arkhiv Patologii,44, 35–40.

    CAS  PubMed  Google Scholar 

  14. Van den Borst, B., Gosker, H. R., Zeegers, M. P., & Schols, A. M. (2010). Pulmonary function in diabetes: A meta-analysis. Chest,138(2), 393–406.

    Article  PubMed  Google Scholar 

  15. Zheng, F., Lu, W., Wu, F., Li, H., Hu, X., & Zhang, F. (2010). Recombinant decorin ameliorates the pulmonary structure alterations by down-regulating transforming growth factor-beta1/SMADS signaling in the diabetic rats. Endocrine Research,35, 35–49.

    Article  CAS  PubMed  Google Scholar 

  16. Eren, G., Cukurova, Z., Hergunsel, O., Demir, G., Kucur, M., Uslu, E., et al. (2010). Protective effect of the nuclear factor kappa B inhibitor pyrrolidine dithiocarbamate in lung injury in rats with streptozotocin-induced diabetes. Respiration,79, 402–410.

    Article  CAS  PubMed  Google Scholar 

  17. Sonali, S., & Xu, S. W. (2010). Patricia L Selective Expression of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue fibrosis. Arthritis and Rheumatism,62, 1523–1532.

    Article  CAS  Google Scholar 

  18. Ponticos, M., Holmes, A. M., Shi-wen, X., Leoni, P., Khan, K., Rajkumar, V. S., et al. (2009). Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen. Arthritis and Rheumatism,60, 2142–2155.

    Article  CAS  PubMed  Google Scholar 

  19. Sato, S., Nagaoka, T., Hasegawa, M., Tamatani, T., Nakanishi, T., Takigawa, M., et al. (2000). Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis. Journal of Rheumatology,27, 149–154.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Respiratory Medicine, The Second Hospital of Jilin University, Changchun, 130041, China

    Yuxin Hu, Zhongsen Ma, Fenglian Zhao, Yuan Wang & Junling Yang

  2. Department of Clinic Laboratory, The First Hospital of Jilin University, Changchun, 130021, China

    Zhimin Guo

  3. Department of Pediatrics, University of Louisville, Louisville, KY, 40202, USA

    Lu Cai

Authors
  1. Yuxin Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhongsen Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zhimin Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Fenglian Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yuan Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lu Cai
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Junling Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Junling Yang.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hu, Y., Ma, Z., Guo, Z. et al. RETRACTED ARTICLE: Type 1 Diabetes Mellitus is an Independent Risk Factor for Pulmonary Fibrosis. Cell Biochem Biophys 70, 1385–1391 (2014). https://doi.org/10.1007/s12013-014-0068-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12013-014-0068-4

Keywords

Search

Navigation